We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWTR
476
DELISTED
Twitter, Inc.
TWTR
| $5.06M | 0.03% |
83,753
+14,103
| +20% | +$926K |
|
|
BRW
477
Saba Capital Income & Opportunities Fund
BRW
$339M
| $5.05M | 0.03% |
555,018
+12,840
| +2% | +$118K |
|
478
Gabelli Dividend & Income Trust
GDV
$2.66B
| $5.05M | 0.03% |
195,713
+59,032
| +43% | +$1.56M |
|
479
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $5.04M | 0.03% |
67,776
+495
| +0.7% | +$37.7K |
|
|
ICPT
480
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.01M | 0.03% |
337,141
+158,653
| +89% | +$2.54M |
|
|
PPL
481
PPL Corp
PPL
$26.7B
| $4.99M | 0.03% |
179,094
+2,953
| +2% | +$85.2K |
|
482
State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF
EFAX
$518M
| $4.99M | 0.03% |
120,700
+24,000
| +25% | +$1.02M |
|
483
Vanguard Russell 2000 Growth ETF
VTWG
$1.55B
| $4.98M | 0.03% |
23,290
+5,266
| +29% | +$1.15M |
|
|
SGEN
484
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.96M | 0.03% |
29,243
+29,033
| +13,825% | +$4.52M |
|
485
Dow Inc
DOW
$21.2B
| $4.93M | 0.03% |
85,709
+2,144
| +3% | +$131K |
|
486
Gerdau
GGB
$9.7B
| $4.93M | 0.03% |
1,261,937
+692,125
| +121% | +$3.01M |
|
487
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
| $4.93M | 0.03% |
48,950
-1,640
| -3% | -$166K |
|
488
Service Corp International
SCI
$11.6B
| $4.9M | 0.03% |
81,334
+69,961
| +615% | +$4.26M |
|
489
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $4.89M | 0.03% |
264,128
+960
| +0.4% | +$18.3K |
|
490
Palantir
PLTR
$413B
| $4.88M | 0.03% |
202,957
+81,969
| +68% | +$2M |
|
491
PTC Therapeutics
PTCT
$6.12B
| $4.86M | 0.03% |
130,740
+17,593
| +16% | +$723K |
|
492
Hilton Worldwide
HLT
$71.5B
| $4.83M | 0.03% |
36,537
+2,327
| +7% | +$294K |
|
493
Canadian Pacific Kansas City
CP
$80.5B
| $4.79M | 0.03% |
73,608
+5,490
| +8% | +$391K |
|
494
Blue Owl Capital
OBDC
$5.74B
| $4.78M | 0.03% |
338,604
-124,667
| -27% | -$1.81M |
|
495
Realty Income
O
$59.1B
| $4.74M | 0.02% |
75,372
+52,254
| +226% | +$3.53M |
|
496
Bio-Techne
TECH
$11.3B
| $4.72M | 0.02% |
38,968
-2,492
| -6% | -$303K |
|
497
EOG Resources
EOG
$70.7B
| $4.69M | 0.02% |
58,458
+10,714
| +22% | +$781K |
|
498
Acadia Pharmaceuticals
ACAD
$5.03B
| $4.67M | 0.02% |
281,228
+49,644
| +21% | +$957K |
|
499
Aptiv
APTV
$10.3B
| $4.6M | 0.02% |
30,881
+2,136
| +7% | +$333K |
|
500
Verisk Analytics
VRSK
$25B
| $4.59M | 0.02% |
22,902
+2,046
| +10% | +$396K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.